Copy
See below for a daily digest of the latest Huntington's Disease news!

Phase 2 Study Finds Evidence of Slowed Disease Progression in Huntington’s Patients

Sep 22, 2016 11:32 am | Daniela Semedo, PhD

 

oral Huntington's therapyTeva Pharmaceutical presented encouraging top-line data from PRIDE-HD, a Phase 2 clinical trial evaluating the impact of pridopidine, an oral medication, on motor impairment in patients with Huntington’s disease (HD). Teva is now preparing for a larger clinical study in Huntington’s. The presentation took place at the 9th European Huntington Disease Network Plenary Meeting in The Hague, Netherlands on Sept. 18. […]

The post Phase 2 Study Finds Evidence of Slowed Disease Progression in Huntington’s Patients appeared first on Huntington's Disease News.

Read More
share on Twitter Like Phase 2 Study Finds Evidence of Slowed Disease Progression in Huntington’s Patients on Facebook

Huntington’s Mice with Common Human Infection Shows Immune Impact on Disease

Sep 20, 2016 01:42 pm | Magdalena Kegel

 

huntington's mouse modelMice models of Huntington’s disease, infected with a parasite commonly found in humans, react in a different way to the infection than normal mice, researchers have revealed. The study suggests that infection and immune activation can impact the course of the neurodegenerative disease. Although researchers behind the study declined to speculate on the possibility that the […]

The post Huntington’s Mice with Common Human Infection Shows Immune Impact on Disease appeared first on Huntington's Disease News.

Read More
share on Twitter Like Huntington’s Mice with Common Human Infection Shows Immune Impact on Disease on Facebook

Recent Posts

Single Injection Silenced Huntington’s Gene Activity for 6 Months in Mice
Voyager Partners with CHDI to Develop Huntington’s Disease Gene-silencing Therapy
Researchers Reverse Huntington’s Defects in Cell Model
Inflammatory Processes in Huntington’s: Researchers Seek to Understand Influence on Disease
Huntington’s Pattern of Neuronal Loss Corresponds with Symptom Type, Researchers Find

Copyright © 2016 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences